ZA 66 125 mg (Divalproex Sodium Delayed-Release (Sprinkle) 125 mg)

Pill with imprint ZA 66 125 mg is Blue & White, Capsule-shape and has been identified as Divalproex Sodium Delayed-Release (Sprinkle) 125 mg. It is supplied by Zydus Pharmaceuticals.

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA 66 125 mg

Save up to 80% off prescription medications

Click here for your free Discount Card

Divalproex Sodium Delayed-Release (Sprinkle)

Imprint:

ZA 66 125 mg

Strength:

125 mg

Color:

Blue & White

Size:

22.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Zydus Pharmaceuticals

Inactive Ingredients:

FD&C Blue No. 1
hypromelloses
silicon dioxide
triethyl citrate
methacrylic acid
sodium lauryl sulfate
gelatin
magnesium silicate
titanium dioxide
microcrystalline cellulose
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
68084-0313	Amerisource Health Services

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer